HNHeiner Nagursky

Heiner Nagursky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Heiner Nagursky has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alveolar socket preservation with demineralised bovine bone mineral and a collagen matrix

    by Carlo Maiorana, Pier Paolo Poli, Matteo Deflorian, Tiziano Testori, Federico Mandelli, Heiner Nagursky, Raffaele Vinci

    Maiorana C, et al. J Periodontal Implant Sci. 2017 Aug;47(4):194-210. https://doi.org/10.5051/jpis.2017.47.4.194


  • Open Access

    A randomized, controlled, multicentre clinical trial of post‐extraction alveolar ridge preservation

    by Eric Todd Scheyer, Rick Heard, Jim Janakievski, George Mandelaris, Marc L. Nevins, Stephen R. Pickering, Christopher R. Richardson, Bryan Pope, Gregory Toback, Diego Velásquez, et al.

    Aim: To compare the effectiveness of two‐ridge preservation treatments.Materials and Methods: Forty subjects with extraction sockets exhibiting substantial buccal dehiscences were enrolled and randomized across 10 standardized centres. Treatments were demineralized allograft plus reconstituted and cross‐linked collagen membrane (DFDBA + RECXC) or deproteinized bovine bone mineral with collagen plus native, bilayer collagen membrane (DBBMC + NBCM). Socket dimensions were recorded at baseline and 6 months. Wound closure and soft tissue inflammation were followed post‐operatively, and biopsies were retrieved for histomorphometric analysis at 6 months.Results: Primary endpoint: at 6 months, extraction socket horizontal measures were significantly greater for DBBMC + NBCM (average 1.76 mm greater, p = 0.0256). Secondary and Exploratory endpoints: (1) lingual and buccal vertical bone changes were not significantly different between the two treatment modalities, (2) histomorphometric % new bone and % new bone + graft were not significantly different, but significantly more graft remnants remained for DBBMC; (3) at 1 month, incision line gaps were significantly greater and more incision lines remained open for DFDBA + RECXC; (4) higher inflammation at 1 week tended to correlate with lower ridge preservation results; and (5) deeper socket morphologies with thinner bony walls correlated with better ridge preservation. Thirty‐seven of 40 sites had sufficient ridge dimension for implant placement at 6 months; the remainder were DFDBA + RECXC sites.Conclusion: DBBMC + NBCM provided better soft tissue healing and ridge preservation for implant placement. Deeper extraction sockets with higher and more intact bony walls responded more favourably to ridge preservation therapy.


  • Open Access

    Minimally Invasive Alveolar Ridge Preservation Utilizing anIn SituHardeningβ-Tricalcium Phosphate Bone Substitute: A Multicenter Case Series

    by Minas D. Leventis, Peter Fairbairn, Ashish Kakar, Angelos D. Leventis, Vasileios Margaritis, Walter Lückerath, Robert A. Horowitz, Bappanadu H. Rao, Annette Lindner, Heiner Nagursky

    Ridge preservation measures, which include the filling of extraction sockets with bone substitutes, have been shown to reduce ridge resorption, while methods that do not require primary soft tissue closure minimize patient morbidity and decrease surgical time and cost. In a case series of 10 patients requiring single extraction,in situhardening beta-tricalcium phosphate (β-TCP) granules coated with poly(lactic-co-glycolic acid) (PLGA) were utilized as a grafting material that does not necessitate primary wound closure. After 4 months, clinical observations revealed excellent soft tissue healing without loss of attached gingiva in all cases. At reentry for implant placement, bone core biopsies were obtained and primary implant stability was measured by final seating torque and resonance frequency analysis. Histological and histomorphometrical analysis revealed pronounced bone regeneration (24.4 ± 7.9% new bone) in parallel to the resorption of the grafting material (12.9 ± 7.7% graft material) while high levels of primary implant stability were recorded. Within the limits of this case series, the results suggest thatβ-TCP coated with polylactide can support new bone formation at postextraction sockets, while the properties of the material improve the handling and produce a stable and porous bone substitute scaffoldin situ, facilitating the application of noninvasive surgical techniques.


  • Vertical Ridge Augmentation with Titanium-Reinforced, Dense-PTFE Membranes and a Combination of Particulated Autogenous Bone and Anorganic Bovine Bone–Derived Mineral: A Prospective Case Series in 19 Patients

    by Istvan A. Urban, Jaime L. Lozada, Sascha A. Jovanovic, Heiner Nagursky, Katalin Nagy

    Istvan A. Urban, DMD, MD/Jaime L. Lozada, DMD/Sascha A. Jovanovic, DDS, MS/Heiner Nagursky, PhD/Katalin Nagy, DDS, PhD: Purpose: This prospective case series evaluated the use of a new titanium-reinforced nonresorbable membrane (high-density polytetrafluoroethylene), in combination with a mixture of anorganic bovine bone?derived mineral (ABBM) and autogenous particulated bone, for vertical augmentation of deficient alveolar ridges. Materials and Methods: A mixture of ABBM and autogenous particulated bone was used for vertical ridge augmentation and covered with a new titanium-reinforced nonresorbable membrane. Ridge measurements were obtained before and after the procedure, complications were recorded, and biopsy specimens were taken for histologic examination. Results: Twenty vertical ridge augmentation procedures were carried out in 19 patients. All treated defect sites exhibited excellent bone formation, with an average bone gain of 5.45 mm (standard deviation 1.93 mm). The healing period was uneventful, and no complications were observed. Eight specimens were examined histologically; on average, autogenous or regenerated bone represented 36.6% of the specimens, ABBM 16.6%, and marrow space 46.8%. No inflammatory responses or foreign-body reactions were noted in the specimens. Conclusion: The treatment of vertically deficient alveolar ridges with guided bone regeneration using a mixture of autogenous bone and ABBM and a new titanium-reinforced nonresorbable membrane can be considered successful.


  • Top Cited Papers

    Horizontal Ridge Augmentation with a Collagen Membrane and a Combination of Particulated Autogenous Bone and Anorganic Bovine Bone–Derived Mineral: A Prospective Case Series in 25 Patients

    by Istvan A Urban, Heiner Nagursky, Jaime L Lozada, Katalin Nagy

    Istvan A. Urban, DMD, MD, PhD/Heiner Nagursky, PhD/Jaime L. Lozada, DMD/Katalin Nagy, DDS, PhD: This prospective case series evaluated the use of a resorbable natural collagen membrane with a mixture of autogenous bone and anorganic bovine bone? derived mineral (ABBM) for lateral ridge augmentation and subsequent implant placement. A mixture (1:1) of particulated autogenous bone and ABBM was used for lateral ridge augmentation and covered with a resorbable, natural collagen bilayer membrane to treat knife-edge ridges and prepare them for implant placement. Ridge measurements were obtained pre- and postsurgery, complications recorded, and biopsy specimens examined histologically. Seventysix implants were placed in 25 patients with 31 knife-edge ridge surgical sites. One defect had a bone graft complication (3.2%; exact 95% confidence interval: 0.1%, 16.7%). Clinical measurements revealed an average of 5.68 mm (standard deviation [SD] = 1.42 mm) of lateral ridge augmentation after a mean 8.9-month (SD = 2.1 months) graft healing period. Clinically, all treated ridges were sufficient in width for subsequent implant placement. All implants survived with an average follow-up of 20.88 months (SD = 9.49 months). Histologic analysis of nine surgical sites showed that ABBM was connected with a dense network of newly formed bone with varying degrees of maturation. Histomorphometric analysis demonstrated that autogenous bone represented a mean of 31.0% of the specimens, ABBM 25.8%, and marrow space 43.2%. The treatment of horizontally deficient alveolar ridges with the guided bone regeneration technique using autogenous bone mixed with ABBM and a natural collagen resorbable barrier membrane can be regarded as successful. Implant success and survival need to be confirmed with long-term follow-up examinations. (Int J Periodontics Restorative Dent 2013;33:299?307. doi: 10.11607/prd.1407)


  • Effect of Gabapentin-Lactam and Gamma-Aminobutyric Acid/Lactam Analogs on Proliferation and Phenotype of Ovine Mesenchymal Stem Cells

    by Sebastian Sauerbier, Ralf Gutwald, Margit Wiedmann-Al-Ahmad, Martin Wolkewitz, Jörg Haberstroh, Julia Obermeyer, Arne Kuenz, Helene Betz, Franziska Wolter, Fabian Duttenhoefer, et al.

    Sebastian Sauerbier, MD, DDS/Ralf Gutwald, MD, DDS/Margit Wiedmann-Al-Ahmad, PhD/Martin Wolkewitz, PhD/J?rg Haberstroh, DVM/Julia Obermeyer, DDS/Arne Kuenz, DDS/Helene Betz/Franziska Wolter, DDS/Fabian Duttenhoefer, MD/Rainer Schmelzeisen, MD, DDS/Heiner Nagursky, PhD/Susanne Proksch, DMD/Ali Al-Ahmad, PhD: Purpose: Classic tissue engineering consists of three components: scaffold, cells, and growth or differentiation factors. Currently, expensive bone morphogenetic proteins are the most common substance used for hard tissue regeneration. An alternative could be gamma-aminobutyric acid/lactam (GABA-lactam) analogs. Materials and Methods: The effects of gabapentin-lactam, cis- and trans-8-tertbutyl-GABA-pentinlactam (trans-TB-GBP-L), and phenyl-GABA-lactam were tested in this study on ovine mesenchymal stem cell (MSC) proliferation. MSCs were selected from bone marrow aspirate concentrate by plastic adherence and amplified. Aliquots of the cells were incubated in medium, with four different concentrations of the GABA-lactam analogs dissolved in dimethyl sulfoxide. Cells in medium with and without dimethyl sulfoxide served as controls. Cell proliferation was tested with a nonradioactive assay. Before and after GABA-lactam analog influence, the MSC character was evaluated by the ability of the cells to differentiate into osteoblasts, chondrocytes, and adipocytes. Results: Proliferation was significantly increased under the influence of the analogs, depending on their concentration. MSCs cultured in 1 nmol/L trans-TB-GBP-L showed the highest proliferation rate. The MSC character was not altered. Conclusions: GABA-lactam analogs could be suited to stimulate MSC proliferation for tissue engineering applications. Further in vivo studies are necessary to evaluate the possible clinical potential of GABA-lactam analogs for hard tissue regeneration.


  • Bone Marrow Aspirate Concentrate Used with Bovine Bone Mineral to Reconstruct Vertical and Horizontal Mandibular Defects: Report of Two Techniques

    by Sebastian Sauerbier, Bernd Giessenhagen, Wolfgang Gutwerk, Petra Rauch, Samuel P. Xavier, Toshiyuky Oshima, Heiner Nagursky, Ralf Gutwald, Rainer Schmelzeisen

    Sebastian Sauerbier, MD, DDS/Bernd Giessenhagen, DDS/Wolfgang Gutwerk, DDS/Petra Rauch, DMD, MSc/Samuel P. Xavier, DDS/Toshiyuki Oshima, DDS/Heiner Nagursky/Ralf Gutwald, MD, DDS/Rainer Schmelzeisen, MD, DDS: Purpose: Following initial positive reports of the use of bone marrow aspirate concentrate (BMAC) in combination with bovine bone mineral (BBM) in augmentation procedures, the technique was evaluated in patients with mandibular deficiency. Materials and Methods: Two adult patients required surgical correction of a deficient alveolar ridge (one patient showed horizontal deficiency only, and the other patient presented with horizontal and vertical deficiency) prior to dental implant placement. In both patients, the reconstruction was performed with BBM in combination with mononuclear cells concentrated by the BMAC method using different techniques. Results: The patients recovered well from all surgical procedures. Histologically, there was uniform bone formation, which allowed placement of dental implants. Conclusion: The results suggest that the use of BMAC in combination with BBM, without autogenous bone, has the potential to restore horizontal and vertical mandibular alveolar defects, providing a functional bone structure and allowing dental implant placement for subsequent prosthetic rehabilitation.


    • 24 March 2012
      • Vol. 27  (2) , 449-57

    Incidence, diagnosis, and treatment of sinus graft infection after sinus floor elevation: a clinical study.

    by Istvan A Urban, Heiner Nagursky, Christopher Church, Jaime L Lozada

    The aims of this clinical study were to evaluate the occurrence of sinus graft infection and the results of a planned surgical and pharmacologic treatment regimen to eliminate infections and preserve the graft. Patients were consecutively treated with sinus floor elevations using the lateral window technique. If a clinical diagnosis of sinus graft infection was made for a patient, a postoperative computed tomographic scan was performed to diagnose involvement of the sinus cavity. Of 198 patients treated with 274 sinus grafts, 8 (2.3%) developed a sinus graft infection. These patients were treated with the same surgical and pharmacologic regimen. Symptoms of infection were recognized, the infected graft was removed, and the remaining graft material was cleansed. The remaining defect was not filled with new graft material; instead, it was left to heal for an extended healing period (average of 10.6 months), and residual bone defects were corrected during implant placement. Acute symptoms of infection disappeared within 48 hours of treatment and all patients healed uneventfully thereafter. All 24 implants placed have survived to date (with implant loading times ranging from 1 to 9 years), resulting in a 100% implant survival rate for these sites with postoperative infection. The overall clinical outcome, including patient satisfaction, achievement of optimal graft volume without subsequent sinus elevation, and long-term implant survival, confirmed the success of this treatment protocol.


  • Making bone II: maxillary sinus augmentation with mononuclear cells—case report with a new clinical method

    by Rainer Schmelzeisen, Ralf Gutwald, Toshiyuki Oshima, Heiner Nagursky, Michael Vogeler, Sebastian Sauerbier


  • Bone Marrow Concentrate and Bovine Bone Mineral for Sinus Floor Augmentation: A Controlled, Randomized, Single-Blinded Clinical and Histological Trial—Per-Protocol Analysis

    by Sebastian Sauerbier, Daniela Rickert, Ralf Gutwald, Heiner Nagursky, Toshiyuki Oshima, Samuel P. Xavier, Johannes Christmann, Patrick Kurz, Dieter Menne, Arjan Vissink, et al.

    The purpose of this work was to evaluate the potential of substituting autogenous bone (AB) by bone marrow aspirate concentrate (BMAC). Both AB and BMAC were tested in combination with a bovine bone mineral (BBM) for their ability of new bone formation (NBF) in a multicentric, randomized, controlled, clinical and histological noninferiority trial. Forty-five severely atrophied maxillary sinus from 26 patients were evaluated in a partial cross-over design. As test arm, 34 sinus of 25 patients were augmented with BBM and BMAC containing mesenchymal stem cells. Eleven control sinus from 11 patients were augmented with a mixture of 70% BBM and 30% AB. Biopsies were obtained after a 3-4-month healing period at time of implant placement and histomorphometrically analyzed for NBF. NBF was 14.3%±1.8% for the control and nonsignificantly lower (12.6%±1.7%) for the test (90% confidence interval: -4.6 to 1.2). Values for BBM (31.3%±2.7%) were significantly higher for the test compared with control (19.3%±2.5%) (p<0.0001). Nonmineralized tissue was lower by 3.3% in the test compared with control (57.6%; p=0.137). NBF after 3-4 months is equivalent in sinus, augmented with BMAC and BBM or a mixture of AB and BBM. This technique could be an alternative for using autografts to stimulate bone formation.